Cost-effectiveness analysis of dotinurad compared to febuxostat for gout with hyperuricemia in China: a modeling study

Authors

Institutions

Publication Details

Journal
Cost Effectiveness and Resource Allocation
Published
2026-09-30
DOI
https://doi.org/10.1186/s12962-026-00829-7
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Cost-effectiveness analysis of dotinurad compared to febuxostat for gout with hyperuricemia in China: a modeling study

Mingye Zhao, Di Zhang, Wenxi Tang, Ke Wang
Cost Effectiveness and Resource Allocation
Gout, Hyperuricemia, Uric Acid
article

Cost-effectiveness analysis of dotinurad compared to febuxostat for gout with hyperuricemia in China: a modeling study

Mingye Zhao, Di Zhang, Wenxi Tang, Ke Wang
article en

Abstract

No abstract available for this paper.
Cost Effectiveness and Resource Allocation
China Pharmaceutical University (CN)
Decent work and economic growth
Openalex Percentile: Top 12%
Gout, Hyperuricemia, Uric Acid
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cost-effectiveness analysis of dotinurad compared to febuxostat for gout with hyperuricemia in China: a modeling study — Mingye Zhao, Di Zhang, et al. · Cost Effectiveness and Resource Allocation (2026) | TGRS Research Map | TGRS